spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

The CPhI Annual Report

CPhI Worldwide

Take part in pharma’s largest reputation survey


The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients.

CPhI Worldwide is using its unrivalled access to pharmaceutical professionals and supplier companies to produce its third annual global survey of the major trends, changes and developments in the industry. This invaluable research will rank the relative reputations of the major pharma economies – from China and India to the USA, Japan, and Europe – creating pharma league tables across areas such as ‘API production’, ‘finished dosage formulations’, ‘biologics’, ‘growth potential’, ‘innovation’ ‘regulatory acumen’, and ‘drug delivery technology’ amongst others.

Covering small molecule, biologics and drug delivery and packaging, the insights provided are integral to building a global picture of the state and strength of the international pharma industry. Investment decisions and supply-side arrangements can often hinge on this unspoken influence, particularly when working with new partners.

The Report provides the industry with an in-depth, holistic analysis that will help you make better-informed decisions and meet the evolving pharma business landscape.

The results of this survey are completely anonymous and will be available on the CPhI Annual Report webpage. Please take the survey here: https://www.surveymonkey.co.uk/r/CPhIAnnual19

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh
De Facto Communications
T: +44 (0) 203 735 8168
E: a.heeley@defacto.com / a.khalifeh@defacto.com
phone +31 (0)20 708 1637
email cphicustomerservice@ubm.com
web www.cphi.com
email Delhi, India
 
Print this page
Send to a friend
   
spacer
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>


White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement